Consolidated Statements of Operations and Comprehensive Loss - USD ($) |
12 Months Ended | |
|---|---|---|
Feb. 28, 2018 |
Feb. 28, 2017 |
|
| Condensed Consolidated Statements Of Operations And Comprehensive Loss | ||
| Revenue | ||
| Operating Expenses | ||
| Research and development | 6,694,778 | 1,454,440 |
| General and administrative | 6,865,748 | 2,280,281 |
| Depreciation and amortization | 367,176 | 397,445 |
| Foreign exchange loss (gain) | 109,676 | (18,165) |
| Total operating expenses | 14,037,378 | 4,114,001 |
| Net Loss | (14,037,378) | (4,114,001) |
| Other comprehensive loss - | ||
| Foreign currency translation adjustment | (17,889) | (157,142) |
| Comprehensive loss | $ (14,055,267) | $ (4,271,143) |
| Loss per share - Basic and diluted | $ (0.43) | $ (0.13) |
| Weighted average common shares outstanding - Basic and diluted | 32,642,741 | 31,102,004 |